Moderna Reports Successful Coronavirus Vaccine Results
On Monday morning, Moderna (NASDAQ: MRNA) released encouraging interim results from a pivotal study with its coronavirus vaccine candidate, mRNA-1273. The company reported its vaccine appears 94.5% effective after 90 of the first 95 trial volunteers to test positive for COVID-19 were in the placebo group.
Moderna also reported 11 severe cases of COVID-19 at the first interim analysis and that none of them occurred among patients vaccinated with mRNA-1273.
Image source: Getty Images.
Source Fool.com
